Attached files

file filename
8-K/A - CURRENT REPORT - PERNIX THERAPEUTICS HOLDINGS, INC.ptx_8ka.htm
EX-99.4 - UNAUDITED PRO FORMA COMBINED FINANCIAL STATEMENTS - PERNIX THERAPEUTICS HOLDINGS, INC.ptx_ex994.htm
EX-99.3 - PRODUCT LINE FINANCIALS - PERNIX THERAPEUTICS HOLDINGS, INC.ptx_ex993.htm
EX-99.2 - STATEMENT OF ASSETS ACQUIRED - PERNIX THERAPEUTICS HOLDINGS, INC.ptx_ex992.htm
EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - PERNIX THERAPEUTICS HOLDINGS, INC.ptx_ex231.htm
 
EXHIBIT 23.2

 
CONSENT OF INDEPENDENT ACCOUNTANTS

 
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-168877, 333-167327, 333-166062 and 333-175992) and Form S-3 (No. 333-186048) of Pernix Therapeutic Holdings, Inc. of our report dated September 19, 2014 relating to the Statement of Revenues and Certain Direct Expenses, which appears in this Current Report on Form 8-K/A of Pernix Therapeutic Holdings, Inc. dated August 19, 2014.
 

/s/PricewaterhouseCoopers LLP

Philadelphia, Pennsylvania
October 8, 2014